ifosfamide
Showing 26 - 50 of 260
Advanced Solid Tumors Trial in China (MASCT-I, Ifosfamide, PD1 antibody)
Recruiting
- Advanced Solid Tumors
- MASCT-I
- +6 more
-
Beijing, Beijing, China
- +8 more
Dec 29, 2022
NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma Trial in San Francisco, Valhalla (Methotrexate, pralatraxate,,
Recruiting
- NK-Cell Lymphoma
- +2 more
- Methotrexate
- +9 more
-
San Francisco, California
- +1 more
Sep 1, 2021
Unresectable Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)
Active, not recruiting
- Unresectable Sinonasal Tumors
- Cisplatin
- +9 more
-
Brescia, BS, Italy
- +4 more
Apr 8, 2022
Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)
Completed
- Hodgkin's Lymphoma
- Panobinostat
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 10, 2020
Extranodal NK-T-Cell Lymphoma Trial in Seoul (Etoposide, Ifosfamide, Dexamethasone)
Unknown status
- Extranodal NK-T-Cell Lymphoma
- Etoposide
- +5 more
-
Seoul, Seoul, Korea, Republic Of, Korea, Republic of
- +1 more
Oct 21, 2020
Pleuropulmonary Blastoma Trial in Minneapolis (Vincristine, Dactinomycin, Cyclophosphamide)
Active, not recruiting
- Pleuropulmonary Blastoma
- Vincristine
- +4 more
-
Minneapolis, MinnesotaAnne K Harris
May 26, 2021
Sarcoma Trial in Los Angeles (sorafenib, Ifosfamide)
Terminated
- Sarcoma
- sorafenib
- Ifosfamide
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center at UCLA
Jul 29, 2020
Sarcoma Trial in New York (biological, drug, procedure, radiation)
Active, not recruiting
- Sarcoma
- filgrastim
- +10 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 5, 2021
Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in
Completed
- Pleomorphic Rhabdomyosarcoma
- +3 more
- Epirubicin Hydrochloride
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Feb 23, 2022
Lymphoma, Non-Hodgkin Trial in Worldwide (Ibrutinib, Rituximab, Ifosfamide)
Kidney Cancer Trial in France (doxorubicin HCl, ifosfamide)
Completed
- Kidney Cancer
- doxorubicin hydrochloride
- ifosfamide
-
Avignon, France
- +13 more
Feb 18, 2021
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Soft Tissue Sarcoma, Bone Sarcoma Trial in Italy, Spain, United Kingdom (Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent], Nivolumab
Recruiting
- Soft Tissue Sarcoma
- Bone Sarcoma
- Sunitinib 37.5 MG, Sunitinib 25 MG [Sutent]
- +7 more
-
Bologna, Italy
- +12 more
Nov 10, 2021
Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)
Recruiting
- Sarcoma, Soft Tissue
- Sintilimab
- +2 more
-
Shanghai, Shanghai, ChinaFudan University, Cancer Hospital
Jul 13, 2020
Locally Advanced Sarcoma Trial in Houston (Dexamethasone, Doxorubicin, Fosaprepitant Dimeglumine)
Terminated
- Locally Advanced Sarcoma
- Dexamethasone
- +9 more
-
Houston, TexasM D Anderson Cancer Center
Aug 5, 2021
Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor Trial in Villejuif (carboplatin, cisplatin, cyclophosphamide)
Completed
- Extragonadal Germ Cell Tumor
- Testicular Germ Cell Tumor
- carboplatin
- +8 more
-
Villejuif, FranceInstitut Gustave Roussy
Feb 19, 2021
Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Classic Hodgkin Lymphoma, Recurrent
Not yet recruiting
- Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma
- +21 more
- Biopsy
- +8 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 7, 2023
Germ Cell Tumor Trial in Bratislava (Paclitaxel, Ifosfamide, Cisplatin)
Completed
- Germ Cell Tumor
- Paclitaxel
- +2 more
-
Bratislava, SlovakiaNational Cancer Institute
Aug 5, 2020
Lymphoma, Non-Hodgkin, Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma Trial in Vancouver (Cyclophosphamide,
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Advanced Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Cyclophosphamide
- +14 more
-
Vancouver, British Columbia, CanadaBC Cancer Agency
Jul 20, 2021
Hodgkin Disease Trial in Belgium, France (Brentuximab Vedotin, Etoposide, Carboplatine)
Completed
- Hodgkin Disease
- Brentuximab Vedotin
- +3 more
-
Bruxelles, Belgium
- +18 more
Dec 6, 2021